Fluidigm to Present at Upcoming Health Care Investor Conference
November 10 2020 - 8:30AM
Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology
tools provider with a vision to improve life through comprehensive
health insight, announced today that the company’s management will
participate in investor meetings and present updates regarding
Fluidigm’s business strategy and financial performance at the
Stifel Virtual Healthcare Conference.
Chris Linthwaite, President and CEO, will give a formal
presentation on Tuesday, November 17, 2020, at 2:00 pm ET. A live
webcast of the company’s presentation and subsequent replay will be
available in the Events & Presentations section of the
Company’s investor website. The webcast will be archived for 90
days following the live presentation.
About Fluidigm Fluidigm (Nasdaq:FLDM)
focuses on the most pressing needs in translational and clinical
research, including cancer, immunology, and immunotherapy. Using
proprietary CyTOF® and microfluidics technologies, we develop,
manufacture, and market multi-omic solutions to drive meaningful
insights in health and disease, identify biomarkers to inform
decisions, and accelerate the development of more effective
therapies. Our customers are leading academic, government,
pharmaceutical, biotechnology, plant and animal research, and
clinical laboratories worldwide. Together with them, we strive to
increase the quality of life for all. For more information,
visit fluidigm.com.
Fluidigm, the Fluidigm logo, and CyTOF are trademarks and/or
registered trademarks of Fluidigm Corporation in the United States
and/or other countries. All other trademarks are the sole property
of their respective owners. Fluidigm products are provided for
Research Use Only. Not for use in diagnostic procedures.
Available InformationWe use our website
(fluidigm.com), investor site (investors.fluidigm.com), corporate
Twitter account (@fluidigm), Facebook page (facebook.com/Fluidigm),
and LinkedIn page (linkedin.com/company/fluidigm-corporation) as
channels of distribution of information about our products, our
planned financial and other announcements, our attendance at
upcoming investor and industry conferences, and other matters. Such
information may be deemed material information, and we may use
these channels to comply with our disclosure obligations under
Regulation FD. Therefore, investors should monitor our website and
our social media accounts in addition to following our press
releases, SEC filings, public conference calls, and
webcasts.
Contact:
Fluidigm Corporation
Agnes LeeVice President, Investor Relations650 416
7423agnes.lee@fluidigm.com
Fluidigm (NASDAQ:FLDM)
Historical Stock Chart
From Aug 2024 to Sep 2024
Fluidigm (NASDAQ:FLDM)
Historical Stock Chart
From Sep 2023 to Sep 2024